J Korean Ophthalmol Soc > Volume 49(9); 2008 > Article
Journal of the Korean Ophthalmological Society 2008;49(9):1483-1490.
DOI: https://doi.org/10.3341/jkos.2008.49.9.1483    Published online September 15, 2008.
Clinical Features in Korean Patients with Sarcoid Uveitis.
Tae Wan Kim, Hum Chung, Hyeong Gon Yu
1Department of Ophthalmology, Seoul Metropolitan Boramae Hospital, Seoul, Korea.
2Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea. hgonyu@snu.ac.kr
3Medical Research Center, Seoul National University, Seoul, Korea.
한국인에서 발생한 사르코이드 포도막염의 임상 양상
김태완1,2,3ㆍ정흠2ㆍ유형곤2,3
Department of Ophthalmology, Seoul Metropolitan Boramae Hospital1, Seoul, Korea / Department of Ophthalmology, Seoul National University College of Medicine2, Seoul, Korea / Medical Research Center, Seoul National University3, Seoul, Korea
Abstract
PURPOSE
To investigate the clinical features of Korean patients with sarcoid uveitis. METHODS: The medical records of patients with endogenous uveitis who were recruited from the uveitis clinic at Seoul National University Hospital were reviewed. Sex, age at presentation, ocular symptoms and signs, treatment, complications, and the rate of recurrence were analyzed. RESULTS: Of 440 patients with endogenous uveitis, 31 (7.1%) with sarcoidosis were included. The mean age at onset was 54.5 years. Sarcoidosis patients with uveitis tended to be older than those without uveitis (44.1 years). Uveitis was the primary manifestation of sarcoidosis in 16 of 31 patients (51.6%). Anterior uveitis was the most common in terms of the anatomic location of inflammation (54.8%), and posterior involvement (38.7%) was not rare. Systemic corticosteroid therapy was administered to 28 patients (90.3%). Five patients (16.1%) received corticosteroids combined with immunosuppressive agents. CONCLUSIONS: Sarcoid uveitis is not a rare etiology of endogenous uveitis. Topical or systemic corticosteroids could control inflammation in most cases, but immunosuppressive agents are needed in a small percentage of patients. Steroids combined with immunosuppressive agents can prevent severe visual losses in such patients.
Key Words: Immunosuppressive agents;Korean;Sarcoid uveitis;Steroid


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next